Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Tengion (developing autologous neo-organs and tissues for the cardiovascular and genitourinary markets) has raised $50mm with its Series B venture round. Bain Capital (with funds from Brookside Capital) and Quaker BioVentures led the financing and were joined by all of the company's current backers, namely Oak Investment Partners, Johnson & Johnson Development Corp., HealthCap, and L Capital Partners. Tengion plans to use the proceeds to advance its autologous neo-bladder, and to develop a manufacturing facility in PA.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?